Evaluation of the effectiveness of pneumococcal conjugate vaccine for children in Korea with high vaccine coverage using a propensity score matched national population cohort

Objectives: This study was performed to evaluate the vaccine effectiveness (VE) of protein conjugated pneumococcal vaccines (PCV) in children with regard to all-cause pneumonia (ACP), pneumococcal pneumonia (PP), invasive pneumococcal disease (IPD), and acute otitis media (AOM), in a country where t...

Full description

Bibliographic Details
Main Authors: Sangho Sohn, Kwan Hong, Byung Chul Chun
Format: Article
Language:English
Published: Elsevier 2020-04-01
Series:International Journal of Infectious Diseases
Online Access:http://www.sciencedirect.com/science/article/pii/S1201971220300369
id doaj-1d85a19ddfa24bc3a77d2491552fed2a
record_format Article
spelling doaj-1d85a19ddfa24bc3a77d2491552fed2a2020-11-25T02:06:22ZengElsevierInternational Journal of Infectious Diseases1201-97122020-04-0193146150Evaluation of the effectiveness of pneumococcal conjugate vaccine for children in Korea with high vaccine coverage using a propensity score matched national population cohortSangho Sohn0Kwan Hong1Byung Chul Chun2Department of Preventive Medicine, Korea University College of Medicine, Goryeodae-ro 73, Seongbuk-gu, Seoul, 02841, Republic of KoreaDepartment of Preventive Medicine, Korea University College of Medicine, Goryeodae-ro 73, Seongbuk-gu, Seoul, 02841, Republic of KoreaCorresponding author at: Department of Preventive Medicine, Korea University College of Medicine, Moonsook #207, Goryeodae-ro 73, Seongbuk-gu, Seoul, 02841, Republic of Korea.; Department of Preventive Medicine, Korea University College of Medicine, Goryeodae-ro 73, Seongbuk-gu, Seoul, 02841, Republic of KoreaObjectives: This study was performed to evaluate the vaccine effectiveness (VE) of protein conjugated pneumococcal vaccines (PCV) in children with regard to all-cause pneumonia (ACP), pneumococcal pneumonia (PP), invasive pneumococcal disease (IPD), and acute otitis media (AOM), in a country where the unvaccinated group is very small. Methods: Children born between 2013 and 2015 were identified in the national population registry for retrospective observation. Vaccination history from the National Immunization Program registry and medical records from the National Health Insurance System were linked together to set up a cohort. VE based on original and propensity score matched cohorts were estimated and compared. Results: A total of 990 224 children were included and 98% were vaccinated. The crude incidence of ACP, PP, and AOM for the original cohort was heavily skewed to the vaccinated group. Adjusting for age, sex, comorbidity, and healthcare utilization rate, the vaccine was found to be effective against PP (VE 60.15%, 95% confidence interval (CI) 21.21–79.85%) and AOM (VE 19.13%, 95% CI 13.42–24.46%). The propensity score matched cohort showed VE against ACP (5.95%, 95% CI 0.88–11.57%), PP (48.61%, 95% CI 23.60–65.43%), and AOM (33.21%, 95% CI 31.01–35.33%). Conclusions: The direct effect of the PCV program was confirmed for ACP, PP, and AOM. The propensity score matched cohort is a feasible solution for measuring and tracing nationwide VE in countries with a very high level of vaccine coverage. Keywords: Pneumococcal infections, Pneumococcal vaccines, Pediatric immunization, Immunization programs, Population healthhttp://www.sciencedirect.com/science/article/pii/S1201971220300369
collection DOAJ
language English
format Article
sources DOAJ
author Sangho Sohn
Kwan Hong
Byung Chul Chun
spellingShingle Sangho Sohn
Kwan Hong
Byung Chul Chun
Evaluation of the effectiveness of pneumococcal conjugate vaccine for children in Korea with high vaccine coverage using a propensity score matched national population cohort
International Journal of Infectious Diseases
author_facet Sangho Sohn
Kwan Hong
Byung Chul Chun
author_sort Sangho Sohn
title Evaluation of the effectiveness of pneumococcal conjugate vaccine for children in Korea with high vaccine coverage using a propensity score matched national population cohort
title_short Evaluation of the effectiveness of pneumococcal conjugate vaccine for children in Korea with high vaccine coverage using a propensity score matched national population cohort
title_full Evaluation of the effectiveness of pneumococcal conjugate vaccine for children in Korea with high vaccine coverage using a propensity score matched national population cohort
title_fullStr Evaluation of the effectiveness of pneumococcal conjugate vaccine for children in Korea with high vaccine coverage using a propensity score matched national population cohort
title_full_unstemmed Evaluation of the effectiveness of pneumococcal conjugate vaccine for children in Korea with high vaccine coverage using a propensity score matched national population cohort
title_sort evaluation of the effectiveness of pneumococcal conjugate vaccine for children in korea with high vaccine coverage using a propensity score matched national population cohort
publisher Elsevier
series International Journal of Infectious Diseases
issn 1201-9712
publishDate 2020-04-01
description Objectives: This study was performed to evaluate the vaccine effectiveness (VE) of protein conjugated pneumococcal vaccines (PCV) in children with regard to all-cause pneumonia (ACP), pneumococcal pneumonia (PP), invasive pneumococcal disease (IPD), and acute otitis media (AOM), in a country where the unvaccinated group is very small. Methods: Children born between 2013 and 2015 were identified in the national population registry for retrospective observation. Vaccination history from the National Immunization Program registry and medical records from the National Health Insurance System were linked together to set up a cohort. VE based on original and propensity score matched cohorts were estimated and compared. Results: A total of 990 224 children were included and 98% were vaccinated. The crude incidence of ACP, PP, and AOM for the original cohort was heavily skewed to the vaccinated group. Adjusting for age, sex, comorbidity, and healthcare utilization rate, the vaccine was found to be effective against PP (VE 60.15%, 95% confidence interval (CI) 21.21–79.85%) and AOM (VE 19.13%, 95% CI 13.42–24.46%). The propensity score matched cohort showed VE against ACP (5.95%, 95% CI 0.88–11.57%), PP (48.61%, 95% CI 23.60–65.43%), and AOM (33.21%, 95% CI 31.01–35.33%). Conclusions: The direct effect of the PCV program was confirmed for ACP, PP, and AOM. The propensity score matched cohort is a feasible solution for measuring and tracing nationwide VE in countries with a very high level of vaccine coverage. Keywords: Pneumococcal infections, Pneumococcal vaccines, Pediatric immunization, Immunization programs, Population health
url http://www.sciencedirect.com/science/article/pii/S1201971220300369
work_keys_str_mv AT sanghosohn evaluationoftheeffectivenessofpneumococcalconjugatevaccineforchildreninkoreawithhighvaccinecoverageusingapropensityscorematchednationalpopulationcohort
AT kwanhong evaluationoftheeffectivenessofpneumococcalconjugatevaccineforchildreninkoreawithhighvaccinecoverageusingapropensityscorematchednationalpopulationcohort
AT byungchulchun evaluationoftheeffectivenessofpneumococcalconjugatevaccineforchildreninkoreawithhighvaccinecoverageusingapropensityscorematchednationalpopulationcohort
_version_ 1724934385756536832